Showing results (21-30 of 255) with videos related to
Sort By:
Pageof 26
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Drug research. First into human in phase I]B Miletzki, C H GleiterPharmacopsychiatry|November 1, 1996
Adverse CNS-effects of beta-adrenoceptor blockersC H Gleiter, J DeckertBritish Journal of Clinical Pharmacology|April 1, 1994
Maprotiline metabolism appears to co-segregate with the genetically-determined CYP2D6 polymorphic hydroxylation of debrisoquineL Firkusny, C H GleiterJournal of Clinical Pharmacology|September 2, 1998
Assessment of drug accumulation in the evaluation of pharmacokinetic dataI Meineke, C H GleiterDer Internist|October 22, 2003
[Phytotherapeutic medicines. A possible source of drug interactions]K Mörike, C H GleiterDalton Transactions (Cambridge, England : 2003)|December 2, 2004
A stepwise degradation of sterically hindered CpCo-cyclobutadiene complexesCarsten Schaefer, Rolf Gleiter, Frank RomingerClinical Pharmacokinetics|February 5, 2002
Clinical pharmacokinetics of candesartanChristoph H Gleiter, Klaus E MörikeAdvances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J NuttThe Journal of Organic Chemistry|April 23, 2015
Model studies on the dimerization of 1,3-diacetylenesGebhard Haberhauer, Rolf Gleiter, Sven FabigPageof 26